Gene Expression Atlas home | about the project | faq | feedback | blog | das | api | help
MMP2
REST API REST API
Homo sapiens
MMP2 is differentially expressed in 245 experiments: 172 organism parts: liver, lung, ... (170 more);, 209 disease states: normal, glioblastoma, ... (207 more);, 94 cell types 414 cell lines 19 compound treatments and 63 other conditions.
Synonyms TBE-1, CLG4A, CLG4
Orthologs Mmp2 (Mus musculus)   MMP2_CHICK (Gallus gallus)   mmp2 (Danio rerio)   MMP2 (Bos taurus)   ENSCING00000005511 (Ciona intestinalis)   E9PSM5_RAT (Rattus norvegicus)   Mmp1 (Drosophila melanogaster)   mmp2 (Xenopus laevis)   Q9N1P6_CANFA (Canis familiaris)   (Compare orthologs)
Gene Ontology Term angiogenesis, plasma membrane, sarcomere, metalloendopeptidase activity, extracellular space, metallopeptidase activity, peptidase activity, proteinaceous extracellular matrix, metabolic process, metal ion binding, extracellular region, response to hypoxia, intracellular membrane-bounded organelle, nucleus, proteolysis, extracellular matrix, collagen, zinc ion binding, intramembranous ossification, collagen catabolic process, bone trabecula formation, blood vessel maturation, skeletal system morphogenesis, face morphogenesis, cellular response to amino acid stimulus
InterPro Term Hemopexin/matrixin_repeat, Pept_M10_metallopeptidase, Peptidase_Metallo, Peptidoglycan-bd-like, FN_type2_col-bd, Pept_M10A_matrixin
Gene-Disease Assocation TORG-WINCHESTER SYNDROME
UniProt Accession B4DWH3, P08253, Q2EF79, E9PE45
Search EB-eye ENSG00000087245
Show more properties
Experimental Factors
Organism part

studied in E-GEOD-803, E-GEOD-22541, E-GEOD-6573, E-GEOD-3526, E-MTAB-62, ... (31 experiments)

3
1
Number of published studies where the gene is over/under expressed compared to the gene's overall mean expression level in the study.

anatomogram

Cell line

studied in E-GEOD-3860, E-GEOD-5258, E-MEXP-1006, E-GEOD-19639, E-GEOD-19397, ... (31 experiments)

Factor Value U/D Experiments
BT474
2
E-MTAB-62, E-MTAB-37
MOLT4
2
E-MTAB-62, E-MTAB-37
WI38
2
E-MTAB-37, E-MTAB-62
GMO8398C
1
E-GEOD-3860
AMO-1
1
E-MTAB-62
MV4II
1
E-MTAB-37
408 more value(s).


Cell type

studied in E-GEOD-492, E-GEOD-20193, E-GEOD-21668, E-GEOD-3920, E-MEXP-66, ... (41 experiments)

Factor Value U/D Experiments
stromal cell
1
4
E-MEXP-2034, E-GEOD-3998, E-GEOD-1460, E-MEXP-1327, E-GEOD-10797 ... (5 experiments)
partially reprogrammed human induced pluripotent stem cell
2
E-GEOD-18265, E-GEOD-18147
induced pluripotent stem cell
2
E-GEOD-18265, E-GEOD-18147
human embryonic stem cell
2
E-GEOD-20033, E-GEOD-18265
macrophage
1
2
E-GEOD-5099, E-GEOD-3982, E-GEOD-360
endothelial cell
1
2
E-GEOD-19240, E-GEOD-3920, E-GEOD-3998
88 more value(s).


Disease state

studied in E-GEOD-3307, E-GEOD-2466, E-MEXP-1121, E-MTAB-62, E-MTAB-680, ... (61 experiments)

Factor Value U/D Experiments
astrocytoma
3
E-MTAB-37, E-MTAB-62, E-GEOD-4290
acute promyelocytic leukemia
3
E-MTAB-62, E-GEOD-1729, E-GEOD-995
glioblastoma
1
3
E-GEOD-6014, E-MTAB-37, E-GEOD-4290, E-GEOD-4412
adrenocortical carcinoma
2
E-TABM-311, E-GEOD-10927
colon carcinoma
2
E-MTAB-37, E-MTAB-62
gastric carcinoma
2
E-MTAB-37, E-GEOD-15460
203 more value(s).


Compound treatment

studied in E-GEOD-3356, E-TABM-782, E-GEOD-5824, E-MEXP-941, E-MEXP-1269, ... (14 experiments)

Factor Value U/D Experiments
glutamine
2
E-MEXP-1335, E-MEXP-941
5-aza-2'-deoxycytidine + trichostatin A
1
1
E-MEXP-1269
nebivolol
1
E-GEOD-3356
glucose
1
E-MEXP-941
bacterial endotoxin
1
1
E-GEOD-3284
ethanol
4
1
E-MEXP-2241
13 more value(s).


Age at diagnosis

studied in E-GEOD-3494, E-GEOD-4922

Factor Value U/D Experiments
86
1
E-GEOD-3494
86 years
1
E-GEOD-4922


Biopsy tissue
studied in E-GEOD-5851

Biosource provider
studied in E-MTAB-37

BioSourceProvider
studied in E-GEOD-19519, E-GEOD-19480

Blood/non-blood meta-groups
studied in E-MTAB-62

Cancer site
studied in E-GEOD-4271

Cell treatment
studied in E-MEXP-1192

Chromosomal aberration
studied in E-GEOD-1729

Clinical history
studied in E-GEOD-22097, E-TABM-234, E-GEOD-19743, E-GEOD-7967, E-GEOD-21589, ... (7 experiments)

Clinical info
studied in E-GEOD-19743, E-MTAB-37, E-MEXP-1251, E-GEOD-21589, E-GEOD-16363, ... (7 experiments)

Clinical treatment
studied in E-GEOD-2171, E-GEOD-6532

coriell cell line repository identifier
studied in E-GEOD-19519

Developmental stage
studied in E-GEOD-19743, E-GEOD-5999, E-GEOD-20033, E-GEOD-3140, E-GEOD-2666, ... (7 experiments)

dfs time (months)
studied in E-GEOD-21653

Disease staging
studied in E-GEOD-19743, E-GEOD-3325, E-GEOD-22541, E-TABM-147, E-GEOD-21138, ... (6 experiments)

Environmental stress
studied in E-GEOD-1643

Estrogen receptor status
studied in E-GEOD-6532

Ethnic group
studied in E-GEOD-1643

Ethnicity
studied in E-GEOD-16363

Family relationship
studied in E-MEXP-1425

Genetic modification
studied in E-GEOD-7578, E-GEOD-20847, E-GEOD-361, E-MEXP-563

Genotype
studied in E-GEOD-1923, E-TABM-1029, E-GEOD-3494, E-GEOD-2466, E-GEOD-17476, ... (7 experiments)

369 groups
studied in E-MTAB-62

4 groups from blood to incompletely diff
studied in E-MTAB-62

96 groups
studied in E-MTAB-62

Growth condition
studied in E-MEXP-2657, E-GEOD-20540, E-GEOD-20504, E-GEOD-19018, E-GEOD-9764, ... (7 experiments)

Her2 fish
studied in E-GEOD-20194, E-GEOD-16716

Her2 ihc
studied in E-GEOD-20194, E-GEOD-16716

Histology
studied in E-TABM-234, E-GEOD-21653, E-TABM-276

Individual
studied in E-MTAB-197, E-TABM-325, E-GEOD-1926, E-MEXP-2069, E-GEOD-16363, ... (26 experiments)

Infection
studied in E-GEOD-2405, E-GEOD-12254, E-MEXP-561, E-GEOD-980

Injury
studied in E-GEOD-19743

Karyotype
studied in E-GEOD-7214, E-GEOD-22056, E-GEOD-12662

Localisation of metastases
studied in E-GEOD-22541

Material type
studied in E-MEXP-455

15 meta groups
studied in E-MTAB-62

4 meta groups
studied in E-MTAB-62

6 meta groups
studied in E-MTAB-62

Molecular subtype
studied in E-GEOD-21653

organ
studied in E-GEOD-24283

Organism
studied in E-GEOD-426, E-TABM-84

Phase
studied in E-GEOD-4888

Phenotype
studied in E-GEOD-1309, E-GEOD-21750, E-GEOD-1657, E-GEOD-17636, E-GEOD-2487 ... (5 experiments)

Population
studied in E-GEOD-4922

Progesterone receptor status
studied in E-GEOD-6532

Protocol type
studied in E-GEOD-3254, E-GEOD-21837, E-GEOD-19445, E-GEOD-19246, E-GEOD-1343 ... (5 experiments)

Qpcr egfr dct
studied in E-GEOD-5851

RNAi
studied in E-MEXP-2115, E-GEOD-1676, E-MEXP-548, E-GEOD-3697, E-MEXP-1315, ... (6 experiments)

Sample preparation
studied in E-GEOD-16728, E-GEOD-12710

Sample type
studied in E-TABM-783

sampleID
studied in E-GEOD-24283

Sampling time point
studied in E-GEOD-19743, E-GEOD-21374, E-GEOD-18995

Sex
studied in E-GEOD-1643, E-GEOD-19069, E-GEOD-2466, E-GEOD-7307

Stimulation
studied in E-GEOD-4883, E-GEOD-11428

Strain or line
studied in E-TABM-125

Subtype
studied in E-GEOD-24283

Survival time
studied in E-GEOD-3494, E-GEOD-4922, E-GEOD-19188

Test result
studied in E-GEOD-1926, E-TABM-276

Treatment
studied in E-GEOD-19246, E-GEOD-13818, E-GEOD-12198

Treatment code
studied in E-GEOD-20194, E-GEOD-16716

Treatments comments
studied in E-GEOD-20194, E-GEOD-16716

Ttf
studied in E-GEOD-21521

Tumor grading
studied in E-GEOD-4290, E-GEOD-22541, E-GEOD-4922, E-TABM-147

Processing time: 0.478 secs.
 
Gene Expression Atlas 2.0.11.1- 12/23/11 3:09:34 PM